Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
06/2010
06/30/2010EP2201944A2 Substituted 2-Aminoacetamides and the Use Thereof
06/30/2010EP2200988A1 N-benzyl quinoline-6-carboxamide compounds and plant disease controlling method using same
06/30/2010EP2200987A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
06/30/2010EP1575589B1 Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives
06/30/2010CN101759635A 3-aryl quinoline compounds as well as preparation methods and applications thereof
06/29/2010US7745629 Bicyclic derivatives as modulators of ion channels
06/29/2010US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
06/29/2010US7745463 useful for the treatment of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS)
06/29/2010US7745462 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors
06/29/2010US7745445 Compounds and compositions as PPAR modulators
06/29/2010US7745443 antagonists of the interaction between the plasma protein von Willebrand factor (vWF) and the blood platelet receptor glycoprotein Ib-IX-V complex, exhibit anticoagulant effect and are suitable for the therapy and prophylaxis of cardiovascular disorders
06/29/2010CA2522053C Polymorphic form of montelukast sodium
06/24/2010WO2010070615A1 Cysteine protease inhibitors
06/24/2010WO2010070449A2 Highly pure laquinimod or a pharmaceutically acceptable salt thereof
06/24/2010WO2010028015A3 2-oxo-1,2-dihydro-quinoline modulators of immune function
06/24/2010WO2009087098A8 Quinoline derivatives and their use as fungicides
06/24/2010US20100160636 Method for producing optically active amines
06/24/2010US20100160357 Heterobicyclic sphingosine 1-phosphate analogs
06/24/2010US20100160328 New compounds useful for dpp-iv enzyme inhibition
06/24/2010US20100160327 Modified Malonate Derivatives
06/24/2010US20100160326 Pest control agent containing novel pyridyl-methanamine derivative or salt thereof
06/24/2010US20100160313 Discovery of novel anticancer compounds based on conformational sampling of quinoxalinhydrazide pharmacophore
06/24/2010US20100160304 Aromatic sulfone compound as aldosterone receptor modulator
06/24/2010US20100160263 7,9-substituted tetracycline compounds
06/24/2010US20100159596 Small molecule compounds for stem cell differentiation
06/24/2010US20100155714 Organic electroluminescent device
06/24/2010CA2744888A1 Cysteine protease inhibitors
06/23/2010EP2199284A1 Pharmaceutical composition for inhibiting accumulation of amyloid- beta protein
06/23/2010EP2199283A1 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient
06/23/2010EP2197847A1 Deuterated 4 -oxoquinoline derivatives for the treatment of hiv infection
06/23/2010EP2197445A2 Tsh receptor antagonizing tetrahydroquinoline compounds
06/23/2010EP2197271A2 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
06/23/2010CN1909907B Quinoline derivatives and use thereof for preparing mycobacterial inhibitors
06/23/2010CN1821236B Therapeutic heterocyclic compounds
06/23/2010CN101747506A Method for preparing molecularly imprinted polymer enriched with trace enrofloxacin
06/23/2010CN101747268A Method for synthesizing 4-substituted-3-bromo-2-quinolone
06/23/2010CN101747267A Method for synthesizing 4-substituted-3-chlorine-2-carbostyril
06/23/2010CN101747266A 4-substituted methyl-2(1H)-quinolinones compound and synthesis method thereof
06/23/2010CN101747265A Method for preparing 2-cyclopropyl-4-(4'-fluorophenyl) quinoline-3-methanol
06/23/2010CN101747264A Synthetic method of (S)-1,2,3,4-tetrahydroisoquinoline tert-butyrylamide with high optical purity
06/23/2010CN101747262A Electron transporting-injection material and organic electroluminescent device using the same
06/23/2010CN101072762B Phenyl-piperazin methanone derivatives
06/22/2010US7741514 Catalyst comprising N-substituted cyclic imide compound and process for producing organic compound using the catalyst
06/22/2010US7741352 for the treatment or alleviation of pain, headaches, nervous system disorders or trauma, stroke, neurodegenerative diseases, cardiovascular disorders, inflammatory diseases, vision defects, hearing disorders, respiratory system disordres and urinary incontinence
06/22/2010US7741316 Pharmacological uses of azetidine derivatives
06/22/2010US7741102 Surface enhanced (resonance) Raman scattering with 2,4,6-trinitrostyryl-1H-benzotriazole; for detection of explosives and drugs; drug screening
06/22/2010CA2420996C Substituted heterocyclic compounds for treating multidrug resistance
06/22/2010CA2398988C Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient
06/22/2010CA2233550C Symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
06/17/2010WO2010066010A1 Process for the preparation of asymmetrical bis(thiosemicarbazones)
06/17/2010WO2010044981A3 Benzoquinoline inhibitors of vesicular monoamine transporter 2
06/17/2010WO2010027150A3 New preparation of hydroxychloroquine
06/17/2010WO2008050199A3 Substituted phenylmethyl bicyclocarboxyamide compounds
06/17/2010US20100152453 Novel Compounds and Preparation for Montelukast Sodium
06/17/2010US20100152452 Stereoselective synthesis of piperidine derivatives
06/17/2010US20100152451 Optically active cyclic alcohol compound and method for preparing the same
06/17/2010US20100152251 Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
06/17/2010US20100152237 Bis-pyrindino containing compounds for the use in the treatment of cns pathologies
06/17/2010US20100152236 Cyclic amine compound
06/17/2010US20100152207 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
06/17/2010US20100152188 Novel Heterocyclic Compounds
06/17/2010US20100152185 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
06/17/2010US20100152184 Pharmaceutical compounds
06/17/2010US20100152165 Carboxylic acid derivatives
06/17/2010US20100152148 Novel compounds
06/17/2010US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
06/17/2010CA2746070A1 Process for the preparation of asymmetrical bis(thiosemicarbazones)
06/16/2010EP2195316A1 Activators and therapeutic applications thereof
06/16/2010EP2195308A2 Antiinfective flavononol compounds and methods of use thereof
06/16/2010EP2195296A1 Quinoline derivatives as 5ht5a receptor antagonists
06/16/2010EP2195295A1 Method for the preparation of montelukast acid in ionic liquid medium
06/16/2010EP1651958B1 Novel chemiluminescent compounds and their use
06/16/2010CN101740723A Organic electroluminescent device and preparation method thereof
06/16/2010CN101735148A Method for synthesizing dihydroquinoline derivative
06/16/2010CN101735102A Method for synthesizing 2,2-disubstituted acetaldehyde hydrazone at room temperature under low pressure by taking acetylene as raw material
06/15/2010US7737295 1-benzyl-4-[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]imidazolidin-2-one; cholesteryl ester transfer protein inhibitor; raising HDL-cholesterol, reducing LDL-cholesterol; atherosclerosis, antiinflammatory agent; synergistic mixture with other active ingredients
06/15/2010US7737282 amorphous compound of lansoprazole; antiulcer agent
06/15/2010US7737281 Purine based fluorescent dyes
06/15/2010CA2521647C Novel hydroxamates as therapeutic agents
06/15/2010CA2351714C Semi-hydrochloride of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
06/15/2010CA2328440C Heterocyclically substituted amides used as calpain inhibitors
06/10/2010WO2010065932A1 Modified chloroquines with single ring moiety or fused ring moiety
06/10/2010WO2010065905A2 Compounds having antiparasitic or anti-infectious activity
06/10/2010WO2010065838A1 Methods of preparing quinoline derivatives
06/10/2010WO2010064951A1 New quinoline derivatives, a method for the production and the use thereof for treating microbacterial infections and a pharmaceutical composition based on said derivatives
06/10/2010WO2010064871A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/10/2010WO2010064735A1 Quinolone compound and pharmaceutical composition
06/10/2010WO2010064701A1 Pharmaceutical agent comprising quinolone compound
06/10/2010WO2010064257A1 Novel intermediates for producing [r-(e)]-1-[[[1-[3-[2-(7- chloro -quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy- methylethyl) phenyl]propyl]thio] methyl] cyclopropaneacetic acid, monosodium salt and process thereof
06/10/2010WO2010064109A2 An improved process for the preparation of montelukast sodium and its intermediates
06/10/2010US20100145056 Acetyl 2-hydroxy-1,3-diaminoalkanes
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100144787 Quinolines and Their Therapeutic Use
06/10/2010US20100144786 Quinoline derivatives as crth2 receptor ligands
06/10/2010US20100144785 Fungicide n-6-membered fused (hetero) aryl-methylene-n-cycloalkyl carboxamide derivatives
06/10/2010US20100144742 Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
06/10/2010CA2745787A1 Compounds having antiparasitic or anti-infectious activity
06/10/2010CA2745019A1 Quinolone compound and pharmaceutical composition
06/10/2010CA2745015A1 Pharmaceutical agent comprising quinolone compound
06/10/2010CA2744711A1 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 277